<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04204954</url>
  </required_header>
  <id_info>
    <org_study_id>201959B1</org_study_id>
    <nct_id>NCT04204954</nct_id>
  </id_info>
  <brief_title>Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery</brief_title>
  <official_title>A Randomized Controlled Trial of Treatment Efficacy in Ameliorating Demodex Spp. Infestation Among Cases Undergoing Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de La Luz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Claudia Palacio Pastrana, M.D., M.Sc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Samuel J. Avalos Lara, M.D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hector Perez Cano, Ph.D.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bani Antonio-Aguirre, M.D., M.P.H.c.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cristina Mendoza-Velasquez, M.D., M.Sc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azyadeh Camacho-Ordóñez, M.D., M.Sc.c.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Andric C. Perez-Ortiz, M.D., M.P.H.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de La Luz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Demodex blepharitis is a prevalent cause of comorbid infection among individuals undergoing
      cataract surgery. Several complications may arise in the postsurgical period from
      Staphylococcus or Streptococcus co-infections, as Demodex is a vector for these pathogens.
      Hence, prophylactic treatments before cataract surgery may lead to a reduction in
      complication rates. Since Demodex infestation and cataract surgery are two prevalent
      coexisting conditions in the general population, this study aims to test the effect of four
      combined treatments to eradicate or improve the Demodex infestation index before surgery. The
      investigators are conducting a single-blinded randomized trial of four therapies in
      participants undergoing cataract surgery. All participants will or are receiving daily eyelid
      cleansing bid and topical 0.3% ciprofloxacin q4h for three days added to the allocated
      treatment arm. Our four intervention groups are: [1] Blephaclean eye scrubs; [2] 50% dilution
      baby shampoo; [3] tea tree oil shampoo; [4]: topical 0.3% ciprofloxacin alone. To assess
      treatment efficacy, the investigators will perform eyelash hair epilation pre and
      postoperatively. The primary outcome is a change in the mean Demodex spp. infestation index.
      Also, a change in the crude number of Demodex (egg, larvae, nymph, or adult-form) spp. in
      eyelashes after one-week of therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 6, 2019</start_date>
  <completion_date type="Actual">December 13, 2019</completion_date>
  <primary_completion_date type="Actual">November 14, 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients diagnosed with Demodex spp. infestation undergoing cataract surgery were randomly allocated into four comparison groups a control group (standard treatment) and three new modalities of Demodex therapy (Blephaclean, baby shampoo, and tea tree oil) + conventional treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Investigators and outcomes assessors were blinded to the treatment allocation of each participant. Outcome assessors were anterior segment surgeons who evaluated cases prior to cataract surgery. There was no indication of group allocation in the electronic medical records (EMR), only the participation of each candidate in the study. Similarly, investigators were blinded to group allocation and only recorded data directly from EMR. Blinding was kept after data analysis.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Demodex spp. infestation index by intervention group</measure>
    <time_frame>One week.</time_frame>
    <description>Number of demodex (egg, larvae, nymph, adult-form) spp. per eyelash (taken from epilation).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Crude count of Demodex spp. adult-forms (mites) in eyelashes by intervention group</measure>
    <time_frame>One week.</time_frame>
    <description>Number of demodex (egg, larvae, nymph, adult-form) spp. in total (taken from epilation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endophthalmitis in the postoperative period.</measure>
    <time_frame>One week.</time_frame>
    <description>Number of cases diagnosed with endophthalmitis in the postoperative period.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Demodex Infestation</condition>
  <condition>Demodicosis</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Group 1: Topical 0.3% Ciprofloxacin [Cipro]</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Cipro + 50% diluted baby shampoo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with 50% diluted baby shampoo for three days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Cipro + Blephaclean</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with Blephaclean Sterile Eyelid Wipes (Thea Pharmaceuticals) for three days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4: Cipro + Tea tree oil.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ciprofloxacin Ophthalmic Ointment 0.3% every four hours for three days. Twice a day eyelid margin cleansing with tea tree oil shampoo for three days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tea Tree Oil Shampoo</intervention_name>
    <description>Twice a day eyelid margin cleansing for three days.</description>
    <arm_group_label>Group 4: Cipro + Tea tree oil.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ciprofloxacin Ophthalmic Ointment 0.3%</intervention_name>
    <description>Applied topically in the eyelid margin every four hours for three days.</description>
    <arm_group_label>Group 1: Topical 0.3% Ciprofloxacin [Cipro]</arm_group_label>
    <arm_group_label>Group 2: Cipro + 50% diluted baby shampoo</arm_group_label>
    <arm_group_label>Group 3: Cipro + Blephaclean</arm_group_label>
    <arm_group_label>Group 4: Cipro + Tea tree oil.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Baby shampoo</intervention_name>
    <description>Twice a day eyelid margin cleansing for three days.</description>
    <arm_group_label>Group 2: Cipro + 50% diluted baby shampoo</arm_group_label>
    <other_name>50% diluted baby shampoo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blephaclean</intervention_name>
    <description>Twice a day eyelid margin cleansing for three days.</description>
    <arm_group_label>Group 3: Cipro + Blephaclean</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent after explanation of the nature and possible consequences of
             the study.

          -  Clinical diagnosis of cataracts staged with Lens Opacity Classification System III
             based on the American Academy of Ophthalmology and the American Society of Cataract
             and Refractive Surgery guidelines.

          -  No topical antibiotic ointment therapy or eyelid cleansing in the past six months.

          -  No systemic antibiotic or antiparasite treatment in the past six months.

          -  No ocular comorbidities (other than cataracts)

          -  No systemic comorbidities.

        Exclusion Criteria:

          -  Withdrawal from the study.

          -  Minimal changes based on the Lens Opacity Classification System III.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Palacio Pastrana, M.D., M.P.H.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de La Luz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Luz</name>
      <address>
        <city>Mexico City</city>
        <zip>06030</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 14, 2019</study_first_submitted>
  <study_first_submitted_qc>December 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de La Luz</investigator_affiliation>
    <investigator_full_name>Andric C Perez-Ortiz, M.D., M.P.H.</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Parasitic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Tea Tree Oil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

